RT Journal Article
T1 The Role of Oral Contraceptive Pills in Hidradenitis Suppurativa: A Cohort Study.
A1 Montero-Vilchez, Trinidad
A1 Valenzuela-Amigo, Andrea
A1 Cuenca-Barrales, Carlos
A1 Arias-Santiago, Salvador
A1 Leyva-Garcia, Ana
A1 Molina-Leyva, Alejandro
K1 contraceptives
K1 hidradenitis suppurativa
K1 premenstrual syndrome
AB There is a need to establish the role of antiandrogens as an alternative or concomitant therapy for hidradenitis suppurativa (HS). Thus, the objectives of this study are (1) to assess the effectiveness of oral contraceptive pills (OCPs) at week 12 in HS women, and (2) to describe the clinical profile of patients receiving oral contraceptive pills (OCPs). A prospective observational study was designed. This study included 100 participants, 50 women with HS who started OCPs for the first time at our HS Clinic and 50 participants without OCP treatment. The main outcome of interest was the percentage of reduction in total abscess and inflammatory nodule (AN) count at week 12. Thirty-three women received combined OCPs and 17 non-combined OCP. HS patients with OCPs treatment were younger (31.7 vs. 40.9 years, p
PB MDPI AG
SN 2075-1729
YR 2021
FD 2021-07-12
LK http://hdl.handle.net/10668/18308
UL http://hdl.handle.net/10668/18308
LA en
NO Montero-Vilchez T, Valenzuela-Amigo A, Cuenca-Barrales C, Arias-Santiago S, Leyva-García A, Molina-Leyva A. The Role of Oral Contraceptive Pills in Hidradenitis Suppurativa: A Cohort Study. Life (Basel). 2021 Jul 15;11(7):697.
DS RISalud
RD Apr 5, 2025